Varex ImagingFRA:VI4 -2.21%69 EBITDA Margin % is 3.66% as of Mar. 2026, which is 67% below its 10-year median of 11.04. GuruFocus rates FRA:VI4 with a GF Score™ of 69/100 and a GF Value™ of €11.77. The stock has 3 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Varex Imaging ranks worse than 62.5% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Varex Imaging's EBITDA for the
three
months ended in Mar. 2026 was €6.8 Mil. Varex Imaging's Revenue for the
three
months ended in Mar. 2026 was €186.8 Mil. Therefore, Varex Imaging's EBITDA margin for the quarter that ended in Mar. 2026 was 3.66%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Varex Imaging EBITDA Margin % Related Terms
Varex Imaging EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Varex Imaging's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:VI4 vs KIDS, LAB, CATX: EBITDA Margin % Comparison
For the Medical Devices subindustry, Varex Imaging's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Varex Imaging EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Varex Imaging's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Varex Imaging's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Varex Imaging (FRA:VI4) has a EBITDA Margin % of 3.66% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Varex Imaging and its competitors. This is 67% below median its historical median of 11.04. According to the industry distribution chart, Varex Imaging ranks #510 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 62.5%.
Is Varex Imaging's EBITDA Margin % too high?
Varex Imaging's current EBITDA Margin % of 3.66% is 67% below median its 10-year median of 11.04. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Varex Imaging's value of 3.66% is 51% below this industry median. Based on the distribution chart, Varex Imaging ranks #510 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Varex Imaging has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Varex Imaging's EBITDA Margin % compare to KIDS and LAB?
According to the Medical Devices & Instruments industry distribution chart, Varex Imaging ranks #510 out of 816 companies for EBITDA Margin %. This places Varex Imaging in the lower half of its industry. The industry median EBITDA Margin % is 7.48. Varex Imaging's value of 3.66% is 51% below this benchmark. While the company's 10-year median is 11.04 vs. the industry median of 7.48, Varex Imaging has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Varex Imaging's current EBITDA Margin % of 3.66% is 51% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Varex Imaging and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Varex Imaging's current EBITDA Margin % is 3.66%, which is 67% below median its own 10-year median of 11.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Varex Imaging stock overvalued right now?
Varex Imaging (FRA:VI4) has a current EBITDA Margin % of 3.66%. The stock's GF Value™ is €11.77, compared to a current price of €8.85 — trading 24.8% below its estimated fair value. The current EBITDA Margin % is 3.66%, which is 67% below median its 10-year median of 11.04 and 51% below the Medical Devices & Instruments industry median of 7.48. Varex Imaging's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Varex Imaging (FRA:VI4), the current EBITDA Margin % is 3.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Varex Imaging (FRA:VI4) Overvalued in 2026?
Based on GuruFocus' analysis, Varex Imaging stock appears to be undervalued.
The current stock price of €8.85 is trading 24.8% below its estimated GF Value™ of €11.77.
Key valuation signals for FRA:VI4:
EBITDA Margin %: 3.66% (67% below median its 10-year median of 11.04)
GF Value™: €11.77 vs. price of €8.85 (24.8% below fair value)
Industry Position: 51% below the Medical Devices & Instruments median (#510 of 816)
No single metric tells the full story. See the FRA:VI4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
69GF Score
Get the complete analysis for FRA:VI4
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:VI4 has been successfully added to your 
